Utility of recent studies to assess the National Research Council 2001 estimates of cancer risk from ingested arsenic

Environmental Health Perspectives

Volumn 119, Issue 3, 2011, Pages 284-290

  Gibb, Herman ^a   Haver, Cary ^a   Gaylor, David ^b   Ramasamy, Santhini ^c   Lee, Janice S ^c   Lobdell, Danelle ^d   Wade, Timothy ^d   Chen, Chao ^c   White, Paul ^c   Sams, Reeder ^c  

^a Tetra Tech Sciences   (United States)

^b Gaylor and Associates LLC   (United States)

^c U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^d U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Arsenic; Bladder; Cancer; Dose response; Drinking water; Lung; Risk assessment

Indexed keywords

ARSENIC; DRINKING WATER;

AGE; ARSENIC POISONING; BLADDER CANCER; CANCER RISK; ENVIRONMENTAL EXPOSURE; FLUID INTAKE; HUMAN; LONG TERM EXPOSURE; LUNG CANCER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; RISK ASSESSMENT; SMOKING; TAIWAN; WATER CONTAMINATION;

ARSENIC; ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGIC STUDIES; HUMANS; LUNG NEOPLASMS; NATIONAL ACADEMY OF SCIENCES (U.S.); RISK ASSESSMENT; UNITED STATES; URINARY BLADDER NEOPLASMS; WATER POLLUTANTS, CHEMICAL;

EID: 79952349841     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1002427     Document Type: Review

References (48)

1. Adair BM, Hudgens EE, Schmitt MT, Calderon RL, Thomas DL. 2006. Total arsenic concentrations in toenails quantified by two techniques provide a useful biomarker of chronic arsenic exposure in drinking water. Environ Res 101(2):213-220.
2. Ahsan H, Chen Y, Parvez F, Argos M, Hussain AI, Momotaj H, et al. 2006. Health Effects of Arsenic Longitudinal Study (HEALS): description of a multidisciplinary epidemiologic investigation. J Expo Sci Environ Epidemiol 16(2):191-205.
3. American Cancer Society. 2010. Cancer Facts and Figures. Available: http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-026238.pdf [accessed 2 February 2011].
4. Baastrup R, Sørensen M, Balstrøm T, Frederiksen K, Larsen CL, Tjønneland A, et al. 2008. Arsenic in drinking-water and risk for cancer in Denmark. Environ Health Perspect 116(2):231-237.
5. Bates MN, Rey OA, Biggs ML, Hopenhayn C, Moore LE, Kalman D, et al. 2004. Case-control study of bladder cancer and exposure to arsenic in Argentina. Am J Epidemiol 159(4):381-389.
6. Bates MN, Smith AH, Cantor KP. 1995. Case-control study of bladder cancer and arsenic in drinking water. Am J Epidemiol 141(6):523-530.
7. Cantor K, Lubin J. 2007. Arsenic, internal cancers, and issues in inference from studies of low-level exposures in human populations. Toxicol Appl Pharmacol 222(3):252-257.
8. Chen CJ, Chen CW, Wu MM, Kuo TL. 1992. Cancer potential in liver, lung, bladder, and kidney due to ingested inorganic arsenic in drinking water. Br J Cancer 66(5):888-892.
9. Chen CJ, Chuang YC, Lin TM, Wu HY. 1985. Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: high-arsenic artesian well water and cancers. Cancer Res 45(11 Pt 2):5895-5899.
10. Chen CJ, Kuo TL, Wu MW. 1988b. Arsenic and cancers [Letter]. Lancet 1(8582):414-415.
11. Chen CJ, Wu MM, Lee SS, Wang JD, Cheng SH, Wu HY. 1988a. Atherogenicity and carcinogenicity of high-arsenic artesian well water. Multiple risk factors and related malignant neoplasms of blackfoot disease. Arteriosclerosis 8(5):452-460.
12. Chen CL, Chiou HY, Hsu LI, Hsueh YM, Wu MM, Chen CJ. 2010a. Ingested arsenic, characteristics of well water consumption and risk of different histological types of lung cancer in northeastern Taiwan. Environ Res 110(5):455-462.
13. Chen CL, Chiou HY, Hsu LI, Hsueh YM, Wu MM, Wang YH, et al. 2010b. Arsenic in drinking water and risk of urinary tract cancer: a follow-up study from northeastern Taiwan. Cancer Epidemiol Biomarkers Prev 19(1):101-110.
14. Chen CL, Hsu LI, Chiou HY, Hsueh YM, Chen SY, Wu MM, et al. 2004. Ingested arsenic, cigarette smoking, and lung cancer risk: a follow-up study in arseniasis-endemic areas in Taiwan. JAMA 292(24):2984-2990.
15. Chen Y, Parvez F, Gamble M, Islam T, Ahmed A, Argos M, et al. 2009. Arsenic exposure at low-to-moderate levels and skin lesions, arsenic metabolism, neurological functions, and biomarkers for respiratory and cardiovascular diseases: review of recent findings from the Health Effects of Arsenic Longitudinal Study (HEALS) in Bangladesh. Toxicol Appl Pharmacol 239(2):184-192.
16. Ferreccio C, Gonzalez C, Milosavjlevic V, Marshall G, Sancha AM, Smith AH. 2000. Lung cancer and arsenic concentrations in drinking water in Chile. Epidemiology 11(6):673-679.
17. Focazio MJ, Welch AH, Watkins SA, Helsel DR, Horn MA. 1999. A retrospective analysis on the occurrence of arsenic in ground-water resources of the United States and limitations in drinking-water-supply characterizations: U.S. Geological Survey Water-Resources Investigation Report 99-4279, 1999. Available: http://pubs.usgs.gov/wri/wri994279/pdf/wri994279.pdf [accessed 19 October 2010].
18. Halmes NC, Roberts SM, Tolson JK, Portier CJ. 2000. Reevaluating cancer risk estimates for short-term exposure scenarios. Toxicol Sci 58(1):32-42.
19. Han YY, Weissfeld JL, Davis DL, Talbott EO. 2009. Arsenic levels in ground water and cancer incidence in Idaho: an ecologic study. Int Arch Occup Environ Health 82(7):843-849.
20. Hansen KA. 1998. Current Population Reports: Household Economic Studies. Census Bureau. Seasonality of Moves and Duration of Residence. Available: http://www.census.gov/sipp/p70s/p70-66.pdf [accessed 19 October 2010].
21. Heck JE, Andrew AS, Onega T, Rigas JR, Jackson BP, Karagas MR, et al. 2009. Lung cancer in a U.S. population with low to moderate arsenic exposure. Environ Health Perspect 117(11):1718-1723.
22. IARC (International Agency for Research on Cancer). 2007. PDFs Online-Cancer Epidemiology. Cancer Incidence in Five Continents, Vol. IX. IARC Scientific Publication No. 160 (Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, et al., eds). Available: http://www.iarc.fr/en/publications/pdfs-online/epi/sp160/index.php [accessed 19 October 2010].
23. IARC (International Agency for Research on Cancer). 2008. Globocan 2008. Cancer Incidence and Mortality Worldwide in 2008. Available: http://globocan.iarc.fr/ [accessed 19 October 2010].
24. Karagas MR, Tosteson TD, Blum J, Klaue B, Weiss JE, Stannard V, et al. 2000. Measurement of low levels of arsenic exposure: a comparison of water and toenail concentrations. Am J Epidemiol 152(1):84-90.
25. Karagas MR, Tosteson TD, Morris JS, Demidenko E, Mott LA, Heaney J, et al. 2004. Incidence of transitional cell carcinoma of the bladder and arsenic exposure in New Hampshire. Cancer Causes Control 15(5):465-472.
26. Kile ML, Houseman EA, Breton CV, Quamruzzaman Q, Rahman M, Mahiuddin G, et al. 2007. Association between total ingested arsenic and toenail arsenic concentrations. J Environ Sci Health A Tox Hazard Subst Environ Eng 42(12):1827-1834.
27. Kurttio P, Pukkala E, Kahelin H, Auvinen A, Pekkanen J. 1999. Arsenic concentrations in well water and risk of bladder and kidney cancer in Finland. Environ Health Perspect 107:705-710.
28. Lamm SH, Engel A, Kruse MB, Feinleib M, Byrd DM, Lai S, et al. 2004. Arsenic in drinking water and bladder cancer mortality in the United States: an analysis based on 133 U.S. counties and 30 years of observation. J Occup Environ Med 46(3):298-306.
29. Marshall G, Ferreccio C, Yuan Y, Bates MN, Steinmaus C, Selvin S, et al. 2007. Fifty-year study of lung and bladder cancer mortality in Chile related to arsenic in drinking water. J Natl Cancer Inst 99(12):920-928.
30. Mehta CR, Hilton JF. 1993. Exact power of conditional and unconditional tests: going beyond the 2 × 2 contingency table. Am Stat 47(2):91-98.
31. Meliker JR, Slotnick MJ, Avruskin GA, Schottenfeld D, Jacquez GM, Wilson ML, et al. 2010. Lifetime exposure to arsenic in drinking water and bladder cancer: a population-based case-control study in Michigan, USA. Cancer Causes Control 21(5):745-757.
32. Meliker JR, Wahl RL, Cameron LL, Nriagu JO. 2007. Arsenic in drinking water and cerebrovascular disease, diabetes mellitus, and kidney disease in Michigan: a standardized mortality ratio analysis. Environ Health 6:4; doi:10.1186/1476-069X-6-4 [Online 2 February 2007].
33. Michaud DS, Wright ME, Cantor KP, Taylor PR, Virtamo J, Albanes D. 2004. Arsenic concentrations in prediagnostic toenails and the risk of bladder cancer in a cohort study of male smokers. Am J Epidemiol 160(9):853-859.
34. Mostafa MG, McDonald JC, Cherry NM. 2008. Lung cancer and exposure to arsenic in rural Bangladesh. Occup Environ Med 65(11):765-768.
35. National Academies Press. 2001. Table S-1: Arsenic in Drinking Water: 2001 Update, 2001. Washington, DC:National Academies Press, 12.
36. NCI (National Cancer Institute). 2010. SEER 17 Registries Incidence and Mortality (2008 Submission), with Kaposi Sarcoma and Mesothelioma. Available: http://canques.seer.cancer.gov/cgi-bin/cq_submit?dir=devcan2006&db=1&rpt=TAB&sel=1^3^1^^^0^17&y=Sex^2,3^Site^8,16&dec=2&template=null [accessed 2 February 2011].
37. NRC (National Research Council). 1999. Arsenic in Drinking Water. Washington, DC:National Academy Press. Available: http://www.nap.edu/catalog.php?record_id=6444#toc [accessed 19 October 2010].
38. NRC (National Research Council). 2001. Arsenic in Drinking Water 2001 Update. Washington, DC:National Academy Press. Available: http://www.nap.edu/openbook.php?isbn=0309076293 [accessed 19 October 2010].
39. Slotnick MJ, Nriagu JO. 2006. Validity of human nails as a biomarker of arsenic and selenium exposure: a review. Environ Res 102(1):125-139.
40. Smith AH, Marshall G, Yuan Y, Ferreccio C, Liaw J, von Ehrenstein O, et al. 2006. Increased mortality from lung cancer and bronchiectasis in young adults after exposure to arsenic in utero and in early childhood. Environ Health Perspect 114:1293-1296.
41. Steinmaus C, Yuan Y, Bates MN, Smith AH. 2003. Case-control study of bladder cancer and drinking water arsenic in the western United States. Am J Epidemiol 158(12):1193-1201.
42. Tseng WP, Chu HM, How SW, Fong JM, Lin CS, Yeh S. 1968. Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J Natl Cancer Inst 40(3):453-463.
43. Uchino T, Roychowdhury T, Ando M, Tokunaga H. 2006. Intake of arsenic from water, food, composites and excretion through urine, hair from a studied population in West Bengal, India. Food Chem Toxicol 44(4):455-461.
44. U.S. EPA (U.S. Environmental Protection Agency). 2001a. 40 CFR Parts 9, 141, and 142, National primary drinking water regulations; arsenic and clarifications to compliance and new source contaminants monitoring. Final rule. Fed Reg 66(14):6975-7066.
45. U.S. EPA (U.S. Environmental Protection Agency). 2001b. 40 CFR Parts 9, 141, and 142, National Primary Drinking Water Regulations. Arsenic and clarifications to compliance and new source contaminants monitoring: delay of effective date. Final rule. Fed Regist 66(99):28342-28350.
46. U.S. EPA (U.S. Environmental Protection Agency). 2001c. Arsenic Rule. Rule-making History. Available: http://www.epa.gov/safewater/arsenic/regulations.html [accessed 17 August 2009].
47. Waalkes MP, Ward JM, Liu J, Diwan BA. 2003. Transplacental carcinogenicity of inorganic arsenic in the drinking water: induction of hepatic, ovarian, pulmonary, and adrenal tumors in mice. Toxicol Appl Pharmacol 186(1):7-17.
48. Wu MM, Kuo TL, Hwang YH, Chen CJ. 1989. Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am J Epidemiol 130(6):1123-1132.